June 1, 2026 – Type 1 Diabetes TrialNet (TrialNet), the world’s leading international research network dedicated to the prevention of type 1 diabetes (T1D), today announced the appointment of Michael Haller, MD, as Chair and Carmella Evans-Molina, MD, PhD, as Vice Chair.

June 1, 2026 – Type 1 Diabetes TrialNet (TrialNet), the world’s leading international research network dedicated to the prevention of type 1 diabetes, today announced the appointment of Michael Haller, MD, as Chair and Carmella Evans-Molina, MD, PhD, as Vice Chair.

TrialNet Chair Kevan C. Herold, MD, reflects on advances in type 1 diabetes research and the need to continue testing promising treatments.

Dear TrialNet Family,